Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: ROTH Capital Partners Conference

This year’s annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.

Aeterna Zentaris, Inc. (AEZS) Starts Presentation at 25th Annual ROTH Conference

Aeterna Zentaris is an oncology and endocrinology drug development company that is presently investigating treatments for a variety of unmet medical needs. The company’s product pipeline consists of compounds at all stages of development – from drug discovery to marketed … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

iSatori, Inc. (IFIT) Starts Presentation at 25th Annual ROTH Conference

iSatori is a consumer products firm engaged in the development and sale of nutritional products through online marketing, Fortune 500 retailers and thousands of retail stores across the globe. The company’s nutritional products are developed and sold in the performance, … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Pernix Therapeutics Holdings, Inc. (PTX) Starts Presentation at 25th Annual ROTH Conference

Pernix Therapeutics Holdings is primarily focused on the development and commercialization of branded, generic and OTC pharmaceutical products. The company’s portfolio of branded products includes the Hawthorn Pharmaceuticals’ product line. In the pediatrics market, products include: CEDAX®, an antibiotic for … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

GSI Group, Inc. (GSIG) Starts Presentation at 25th Annual ROTH Conference

GSI Group is a world leader in supplying precision photonic components and subsystems to OEMs in the medical, scientific and microelectronics markets. GSI’s highly engineered solutions include laser sources, scanning and beam delivery products and precision motion control products. The … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

MEI Pharma, Inc. (MEIP) Starts Presentation at 25th Annual ROTH Conference

MEI Pharma is engaged in the clinical development of novel therapies for cancer. The company’s lead drug candidate is Pracinostat inhibitor is being developed for advanced hematologic malignancies such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). MEIP plans … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

CPI Aerostructures, Inc. (CVU) Starts Presentation at 25th Annual ROTH Conference

CPI Aerostructures is a contract producer of structural aircraft parts. CPI Aero serves leading prime defense contractors, the U.S. Air Force and other branches of the armed forces, also acting as a subcontractor in the production of commercial aircraft parts … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Cognex Corporation (CGNX) Starts Presentation at 25th Annual ROTH Conference

Cognex is a global leader in the machine vision industry, designing, developing, manufacturing and marketing a variety of products that incorporate sophisticated machine vision technology that gives them the ability to “see.” The company’s products include barcode readers, machine vision … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Landec Corp (LNDC) Starts Presentation at 25th Annual ROTH Conference

Landec is a materials science company focused on leveraging its proprietary polymer technologies, application development and innovation capabilities for the development and commercialization of new products in the food and biomaterials markets. The company’s two foundational proprietary polymer technology platforms … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Salix Pharmaceuticals (SLXP) Starts Presentation at 25th Annual ROTH Conference

Salix Pharmaceuticals develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. SLXP’s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market these products through the … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Perion Network Ltd. (PERI) Starts Presentation at 25th Annual ROTH Conference

Perion Network is a global consumer internet company that develops applications to enhance users’ online experience. Perion’s three main consumer brands are: Incredimail, a unified messaging application; Smilebox, a photo sharing and social expression product; and SweetIM, an instant messaging … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment